Immunoglobulin-like transcript 3 (ILT3) is an inhibitory receptor expressed on antigen-presenting cells (APCs), and some studies have identified the effect of ILT3-Fc in reducing GVHD, which may be due to induction of CD8+ Tregs (84). Here, CD8A is linked to graft versus host disease.